Preventive Vancomycin Shows Promise Against Recurrent C. Difficile

Preventive Vancomycin Shows Promise Against Recurrent C. Difficile

(MedPage Today) -- Vancomycin appeared to top placebo for lowering Clostridioides difficile infection (CDI) recurrence rates in patients taking other systemic antibiotics for a non-CDI indication, but the underpowered trial didn't deliver conclusive...

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

The injection is indicated for the treatment of sepsis and other serious infections, enhancing treatment efficiency and patient care.

Real-World Use of Fecal Microbiota, live-jslm Shows High Success in Preventing Recurrent C difficile Infection

A multicenter US study confirms that RBL is a safe and effective microbiota-based therapy with sustained remission in a high-risk, comorbid population.